Seroprevalence of SARS-CoV-2 antibodies among blood donors in Québec: an update from a serial cross-sectional study

• Published in: Canadian journal of public health 2022-06, Vol.113 (3), p.385-393
• Main Authors: Lewin, Antoine, De Serres, Gaston, Grégoire, Yves, Perreault, Josée, Drouin, Mathieu, Fournier, Marie-Josée, Tremblay, Tony, Beaudoin, Julie, Boivin, Amélie, Goyette, Guillaume, Finzi, Andrés, Bazin, Renée, Germain, Marc, Delage, Gilles, Renaud, Christian
• Format: Article
• Language: English
• Subjects: Age; Age composition; Antibodies; Antibodies, Viral; Blood; Blood Donors; Coronaviruses; COVID-19; COVID-19 - epidemiology; COVID-19 diagnostic tests; COVID-19 Testing; Cross-Sectional Studies; Enzyme-linked immunosorbent assay; Female; Humans; Male; Medicine; Medicine & Public Health; Middle Aged; Minority & ethnic groups; Pandemics; Public Health; Quebec - epidemiology; SARS-CoV-2; Seroepidemiologic Studies; Serology; Severe acute respiratory syndrome coronavirus 2; Special Section on COVID-19: Quantitative Research; Vaccination; Vaccines; Viral diseases
• ISSN: 0008-4263; 1920-7476
• DOI: 10.17269/s41997-022-00622-y

Objectives We previously estimated the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies following the first pandemic wave at 2.23% in Québec, Canada. Following the much bigger second wave in fall 2020 and early 2021, we estimated the seroprevalence of anti-SARS-CoV-2 in Québec during the first months of 2021. Methods Blood samples from regular, asymptomatic (for ≥ 14 days) donors were collected between January 25, 2021 and March 11, 2021. Anti-SARS-CoV-2 seropositivity was assessed using an enzyme-linked immunosorbent assay that captures antibodies directed against the receptor binding domain of the SARS-CoV-2 spike (and hence cannot discriminate between infection- and vaccine-induced seropositivity). Seroprevalence estimates were adjusted for regional distribution, age, and sex. Results Samples from 7924 eligible donors were analyzed, including 620 (7.8%) vaccinated donors and 7046 (88.9%) unvaccinated donors (vaccination status unknown for 258 (3.3%) donors). Overall, median age was 51 years; 46.4% of donors were female. The adjusted seroprevalence was 10.5% (95% CI = 9.7–11.3) in the unvaccinated population and 14.7% (95% CI = 13.8–15.6) in the overall population. Seroprevalence gradually decreased with age and was higher among donors who self-identified as having a racial/ethnic background other than white, both in the overall and in the unvaccinated populations. Conclusion The seroprevalence of SARS-CoV-2 antibodies significantly increased in Québec since spring 2020, with younger persons and ethnic minorities being disproportionately affected. When compared with the cumulative incidence rate reported by public health authorities (i.e., 3.3% as of March 11, 2021), these results suggest that a substantial proportion of infections remain undetected despite improvements in access to COVID-19 testing.